In 2014, Zealand Pharma’s operating expense completed DKK 1,327 m (USD 185.72 m).
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/zealand-pharma-has-significantly-increased-rd-costs-in-search-of-new-obesity-drug/
Zealand Pharma has significantly increased R&D costs in search of new obesity drug
赞 (0)
关于作者
相关推荐
-
Novo Nordisk CEO makes top 30 in Fortune’s most powerful business leaders ranking
Lars Fruergaard Jørgensen has actually been placed by Ton of money publication as the 29th most effective magnate worldwide, simply defeating the chief executive officer of Eli Lil…
-
LG Energy Solution to Power Electric Versions of Ford’s Commercial Vans in Europe
LG Power Option (KRX: 373220) introduced it authorized supply contracts with Ford Electric motor Business (” Ford”) to power the energized designs of Ford business vans…
-
Almonty and SeAH sign molybdenum offtake agreement for Sangdong mine
Almonty Industries has announced an exclusive offtake agreement with SeAH Group, a leading Korean steel company and SpaceX contractor, to supply the entire production of molybdenum…
-
New Mirai variant ‘Murdoc_Botnet’ targets AVTECH cameras and Huawei routers
Scientists at cybersecurity software application company Qualys Inc. are alerting of a brand-new Mirai botnet variation that’s being utilized to target susceptabilities in AV…
